Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **30S ribosomal subunit protein** refers collectively to the set of proteins that, together with a single molecule of highly conserved 16S rRNA, form the small (30S) subunit of the prokaryotic 70S ribosome. This complex is essential for **protein synthesis** in bacteria. The primary functions include binding messenger RNA (mRNA), ensuring correct placement and reading frame via interaction with the Shine-Dalgarno sequence, and discriminating against incorrect aminoacyl-tRNAs during translation—thereby maintaining fidelity during genetic decoding. The 30S subunit also interacts dynamically with various initiation factors and transfer RNAs at different stages of translation initiation. Structurally, it contains one molecule of **16S rRNA** (~1540 nucleotides) and typically **21 distinct proteins** named S1 through S21. These components are highly conserved across bacteria but show less homology to eukaryotic counterparts than does their rRNA core. The clinical significance arises from its role as a major target for several classes of antibiotics—including aminoglycosides like streptomycin and paromomycin—which bind specific sites on the 30S subunit to disrupt bacterial translation processes. Resistance can develop through mutations affecting these sites. In summary, this target is a well-established molecular machine critical for prokaryotic viability, widely exploited pharmacologically as an antibacterial target.[1][2][4]
Inhibition of translation initiation or elongation by binding to the 30S subunit, interfering with decoding or translocation steps during bacterial protein synthesis[2][6]
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 30S ribosomal subunit protein.